A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients (2014)
- Authors:
- USP affiliated authors: PANNUTI, CLAUDIO MENDES - FO ; NAHAS, WILLIAM CARLOS - FM ; MACHADO, CLARISSE MARTINS - IMT
- Unidades: FO; FM; IMT
- Subjects: INFECÇÕES POR CYTOMEGALOVIRUS; TRANSPLANTE DE RIM; ESTUDOS PROSPECTIVOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical and Transplantation Research
- Volume/Número/Paginação/Ano: v. 98, n. 10, p. 1077-1081, 2014
-
ABNT
DAVID-NETO, Elias; TRIBONI, Ana H. K.; PAULA, Flavio J.; et al. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Clinical and Transplantation Research, Baltimore, v. 98, n. 10, p. 1077-1081, 2014. Disponível em: < doi: 10.1097/TP.0000000000000189 >. -
APA
David-Neto, E., Triboni, A. H. K., Paula, F. J., Vilas Boas, L. S., Machado, C. M., Agena, F., et al. (2014). A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Clinical and Transplantation Research, 98( 10), 1077-1081. Recuperado de doi: 10.1097/TP.0000000000000189 -
NLM
David-Neto E, Triboni AHK, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZA, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients [Internet]. Clinical and Transplantation Research. 2014 ; 98( 10): 1077-1081.Available from: doi: 10.1097/TP.0000000000000189 -
Vancouver
David-Neto E, Triboni AHK, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZA, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients [Internet]. Clinical and Transplantation Research. 2014 ; 98( 10): 1077-1081.Available from: doi: 10.1097/TP.0000000000000189 - Infecções virais em receptores de transplante de órgãos sólidos e de medula óssea
- Transplant-associated and blood transfusion-associated tropical and parasitic infections
- Reimunization after bone marrow transplantation :: current recommendations and perspctives
- Influenza infections after hematopoietic stem cell transplantation
- Monitoring for HHV-6 infection after renal transplantation:: evaluation of risk factors for sustained viral replication
- Baixas doses de ganciclovir na profilaxia da doenca pelo citomegalovirus pos transplante de medula ossea
- Loss of hepatitis A virus antibodies after bone marrow transplantation
- Chagas disease in transplantation:: time to enter an era of better diagnosis and better outcomes [Editorial]
- Chikungunya, Dengue, and Zika in immunocompromised hosts
- Diagnosis of antibody-mediated rejeiction through early protocol biopsies in sensitized patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
